CAPITAL PERFORMANCE ADVISORS LLP – Protalix BioTherapeutics, Inc. Transaction History
CAPITAL PERFORMANCE ADVISORS LLP portfolio value:
$27,000
portfolio value
CAPITAL PERFORMANCE ADVISORS LLP quarter portfolio value change:
-4.46%
quarter
Protalix BioTherapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1K | $1.04 | 25.97K | |
| Q2 2022 | share | Increase | 0.00% | 25.97K shares | 28K | $1.09 | 25.97K |